SINOPHARM (01099) rose 3.2% to HK$21.1, breaking above the 50-D SMA of HK$20.773.
It hits an intra-day high of HK$21.1, and an intra-day low of HK$20.35. The total shares traded was 2.9 million, with a value of HK$60.36m. The active buy/sell ratio is 72:28, with net buying turnover of HK$23.19m. CLSA LTD accounts for greatest net responsive buying turnover of HK$1.76m, with volume weighted average price of HK$20.827. BOCI SEC accounts for greatest net responsive selling turnover of HK$3.37m, with volume weighted average price of HK$20.99. The stock has risen a combined 8.7% over the past 4 consecutive trading days.
The Hang Seng Index now rose 11 points, or less than 0.1% to 18,490.
Nominal | 21.100 | % Chg | +3.18% |
High | 21.100 | Low | 20.350 |
Shares Tr | 2.9m | Turnover | 60.36m |
10-D SMA | 20.578 | %H.V | 38.831 |
20-D SMA | 20.277 | VWAP | 20.794 |
50-D SMA | 20.773 | RSI14 | 56.357 |
Stock (Code) | Price (HK$) | Change (%) |
---|---|---|
SINOPHARM (01099) | 21.10 | +3.18 |
ALI HEALTH (00241) | 3.02 | -0.98 |
TRAD CHI MED (00570) | 4.29 | -0.23 |
CSPC PHARMA (01093) | 6.70 | +0.60 |
SINO BIOPHARM (01177) | 2.97 | +3.12 |
SH PHARMA (02607) | 11.32 | -0.35 |
CHINARES PHARMA (03320) | 5.29 | -0.56 |
HANSOH PHARMA (03692) | 18.00 | -1.75 |
SCICLONE PHARMA (06600) | 18.18 | +0.22 |
JD HEALTH (06618) | 29.00 | -1.02 |
etnet榮獲HKEX Awards 2023 「最佳表現證券數據供應商」大獎► 了解詳情